Skip to content

Intermittent CPAP in hypoxemic COVID patients

Comparative Trial of Intermittent CPAP use in Hypoxemic Patients with COVID-19 infection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200723048178N2
Enrollment
93
Registered
2021-04-28
Start date
2021-05-02
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Infection. Pneumonia due to SARS-associated coronavirus

Interventions

Intervention 1: Intervention group: Patients in the intervention group will be applied CPAP masks for two hours in the morning and two hours in the evenings (total four hours), at least six hours apar

Sponsors

Pakistan Institute of Medical Sciences, Islamabad
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Hospitalized patients with severe COVID-19 infection Patients requiring supplemental oxygen of 10 litres or more

Exclusion criteria

Exclusion criteria: Unco-operative patient Patients with Pneumothorax Patients with Surgical emphysema GCS less than 13 Excessive respiratory secretions Shock

Design outcomes

Primary

MeasureTime frame
In-hospital mortality. Timepoint: 28 days after intervention. Method of measurement: A Questionnaire will be used to record the data.

Secondary

MeasureTime frame
The duration of hospital stay. Timepoint: 28 days following the intervention. Method of measurement: A Questionnaire will be used to record the data.;The use of non-invasive or invasive mechanical ventilation. Timepoint: 28 days after intervention. Method of measurement: A Questionnaire will be used to record the data.

Countries

Pakistan

Contacts

Public ContactAhmed Farhan

Pakistan Institute of Medical Sciences, Islamabad

drfarhan992@gmail.com+92 51 2331590

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026